This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Christopher Williamson Davies: Innovator in Antibody Development
Introduction
Christopher Williamson Davies is a notable inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody therapies. With a total of 2 patents to his name, Davies is recognized for his innovative approaches to medical science.
Latest Patents
Davies' latest patents include "CD8 Binding Agents and Uses Thereof" and "KRAS Specific Antibodies and Uses Thereof." These patents reflect his commitment to advancing therapeutic options for various diseases, showcasing his expertise in antibody engineering.
Career Highlights
Currently, Christopher Williamson Davies is employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to the field.
Collaborations
Some of his notable coworkers include James T. Koerber and Micah Steffek. Their collaborative efforts have played a crucial role in the development of groundbreaking therapies.
Conclusion
Christopher Williamson Davies stands out as a prominent inventor in the biotechnology sector, with a focus on antibody development. His contributions continue to impact the medical field positively.